See All Slides - tctmd.com

Slides

Presentation TCT 2014

For the Proposal!

Presenter: Philip M. Meyers

September 14, 2014

Presentation TCT 2014

Preventive PCI and Deferred Stenting: In Which Patients Is This Ready for Prime Time?

Presenter: Cindy L. Grines, Neal S. Kleiman, George D. Dangas

September 14, 2014

Presentation TCT 2014

Case #1: Crossover Technique for Distal LM

Presenter: Jean Fajadet, Marie-Claude Morice, Seung-Jung Park, Corrado Tamburino

September 14, 2014

Presentation TCT 2014

In the Potent ADP Antagonist Era, Vorapaxar Will Have a Limited Role!

Presenter: Jessica L. Mega, Daniel I. Simon, Franz-Josef Neumann

September 14, 2014

Presentation TCT 2014

Mitral Valve Operative Techniques: Which Make a Measurable Difference? In Which Patients?

Presenter: Steven F. Bolling, A. Pieter Kappetein, Neil E. Moat, David H. Adams

September 14, 2014

Presentation TCT 2014

The MitraSpacer

Presenter: Francesco Maisano, Gregg W. Stone, Brian K. Whisenant, Lars G. Svensson

September 14, 2014

Presentation TCT 2014

TCT 685: Costs of Periprocedural Complications Among Patients Treated with a Self-Expanding Transcatheter Aortic Valve Prosthesis: Results from the CoreValve US Pivotal Extreme-Risk Study

Presenter: Samir R. Kapadia, Patrick T. O'Gara, G. Michael Deeb, Suzanne Baron

September 14, 2014

Presentation TCT 2014

TAVR Alternative Access: Balancing Risks and Benefits of Subclavian, Direct Aortic, and Transapical Approaches

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Michael J. Reardon

September 14, 2014

Presentation TVT 2013

Case Presentation(2)

Presenter: Jean-Michel Paradis

June 12, 2013

Presentation TVT 2013

How Does the Heart Team Use Risk Scores and Other Parameters to Categorize Patients for TAVR in the European Union?

Presenter: A. Pieter Kappetein

June 12, 2013

Advertisement

Slides

For the Proposal!

Preventive PCI and Deferred Stenting: In Which Patients Is This Ready for Prime Time?

Case #1: Crossover Technique for Distal LM

In the Potent ADP Antagonist Era, Vorapaxar Will Have a Limited Role!

Mitral Valve Operative Techniques: Which Make a Measurable Difference? In Which Patients?

The MitraSpacer

TCT 685: Costs of Periprocedural Complications Among Patients Treated with a Self-Expanding Transcatheter Aortic Valve Prosthesis: Results from the CoreValve US Pivotal Extreme-Risk Study

TAVR Alternative Access: Balancing Risks and Benefits of Subclavian, Direct Aortic, and Transapical Approaches

Case Presentation(2)

How Does the Heart Team Use Risk Scores and Other Parameters to Categorize Patients for TAVR in the European Union?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content